XXVI EFMC International Symposium on Medicinal Chemistry

Basel, Switzerland

Sunday, 29 Aug '21

The XXVI EFMC International Symposium on Medicinal Chemistry (EFMC-ISMC 2021)  will continue the tradition established for these biennial symposia of covering advances in drug discovery in major therapeutic areas, including the treatment of bacterial and viral infections, diseases related to the CNS, heart disease, fibrotic diseases and cancer. Recent advances in highly topical areas such as, for example, the application of artificial intelligence in drug discovery and in synthesis, carbohydrate recognition and drug design, the targeting of RNA, small molecule-induced stem cell differentiation, and the impact of cryo-EM on drug discovery and design will also be covered. 

Dr Gary Newton will be presenting a talk entitled "MAP4K4 Inhibitors for the Treatment of Myocardial Infarction" which describes work carried out by Domainex in collaboration with Prof. Michael Schneider and his team at Imperial College.